)
Chris Molloy
CEO
Medicines Discovery Catapult
Chris Molloy is a senior international life sciences executive, scientist, board director and advisor with more than 35 years’ experience across pharmaceuticals, biotechnology, diagnostics, digital health, data science and healthcare innovation.
His career has spanned leadership roles from global drug discovery at Glaxo to venture-backed biotech, R&D technology, executive search and national innovation strategy. He founded and led Medicines Discovery Catapult, the UK’s national centre for drug discovery innovation, and during the COVID-19 pandemic served as founding Director of the UK’s Lighthouse Labs network, the largest diagnostic programmes in British history.
Chris has chaired and advised multiple biotech and healthcare companies, supported governments and investors internationally. He serves as a Trustee of The Institute of Cancer Research, is an Honorary Professor at The University of Manchester, and is Independent Chair of PharosAI.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}